hank kung
University of Pennsylvania
H-index: 91
North America-United States
Top articles of hank kung
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Determining the optimal pharmacokinetic modelling and simplified quantification method of [18F]AlF-P16-093 for patients with primary prostate cancer (PPCa) | European Journal of Nuclear Medicine and Molecular Imaging | Ruiyue Zhao Zeheng Xia Miao Ke Jie Lv Huizhen Zhong | 2024/1/29 |
First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients | European Journal of Nuclear Medicine and Molecular Imaging | Ruiyue Zhao Miao Ke Jie Lv Shaoyu Liu Yuheng Liu | 2024/1/12 |
Comparison of novel PSMA-targeting [177Lu] Lu-P17-087 with its albumin binding derivative [177Lu] Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a … | European Journal of Nuclear Medicine and Molecular Imaging | Linlin Li Jiarou Wang Guochang Wang Rongxi Wang Wenbin Jin | 2024/4/25 |
First-in-human study of D6-[18F] FP-(+)-DTBZ, a novel VMAT2 tracer: whole-body biodistribution and brain PET comparison with [18F] FP-(+)-DTBZ (AV-133) | Ruiyue Zhao Jinhua Chen Ting Ye Jianmin Chu Hank F Kung | 2024/2/28 | |
Serotonin transporter imaging agent as a probe for β-cells of pancreas | Nuclear Medicine and Biology | Yuli Sun Guangwen Li Haiyan Hong Lin Zhu Hank F Kung | 2024/2/24 |
Optimization and scale up of production of the PSMA imaging agent [18F]AlF-P16-093 on a custom automated radiosynthesis platform | EJNMMI Radiopharmacy and Chemistry | David Alexoff Seok Rye Choi Karl Ploessl Dohyun Kim Ruiyue Zhao | 2024/2/23 |
A prospective head-to-head comparison of [68Ga] Ga-HBED-CC-BP and [68Ga] Ga-PSMA-11 PET/CT in patients with bone metastases from prostate cancer | Jiarou Wang Guochang Wang Linlin Li Zhaohui Zhu Lin Zhu | 2023/6/1 | |
Head-to-head comparison of 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT in patients with primary prostate cancer: a pilot study | Clinical Nuclear Medicine | Guochang Wang Linlin Li Jie Zang Haiyan Hong Lin Zhu | 2023/4/1 |
Head-to-head comparison of [68Ga]Ga-P16-093 and 2-[18F]FDG PET/CT in patients with clear cell renal cell carcinoma: a pilot study | European Journal of Nuclear Medicine and Molecular Imaging | Guochang Wang Linlin Li Jiarou Wang Jie Zang Jingci Chen | 2023/4 |
[18F]‐D3FSP amyloid‐β PET imaging in elderly adults and Alzheimer’s disease | Alzheimer's & Dementia | Anqi Li Ruiyue Zhao Mingkai Zhang Pan Sun Yue Cai | 2023/12 |
[68Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake | Molecular Pharmaceutics | Haiyan Hong Zhihao Zha Ruiyue Zhao Yang Luo Wenbin Jin | 2023/3/21 |
Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy | Journal of Medicinal Chemistry | Zhihao Zha Karl Ploessl Seok Rye Choi Ruiyue Zhao Wenbin Jin | 2023/9/5 |
Assessing extra-prostatic extension for surgical guidance in prostate cancer: Comparing two PSMA-PET tracers with the standard-of-care | Urologic oncology: seminars and original investigations | Clinton D Bahler Mark A Green Mark A Tann Jordan K Swensson Katrina Collins | 2023/1/1 |
A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer | European Journal of Nuclear Medicine and Molecular Imaging | Guochang Wang Linlin Li Ming Zhu Jie Zang Jiarou Wang | 2023/8 |
In vivo and in vitro binding of [125I]I‐R‐(+)‐TISCH: A dopamine D1 receptor ligand for studying pancreatic β‐cell mass | Journal of Labelled Compounds and Radiopharmaceuticals | Yan Zhang Guangwen Li Yuli Sun Haiyan Hong Linlin Li | 2022/12 |
Head-to-head comparison of [68 Ga]Ga-P16-093 and [68 Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients | European Journal of Nuclear Medicine and Molecular Imaging | Guochang Wang Haiyan Hong Jie Zang Qingxing Liu Yuanyuan Jiang | 2022/2/1 |
Preliminary Evaluation of 68Ga-P16-093, a PET Radiotracer Targeting Prostate-Specific Membrane Antigen in Prostate Cancer | Molecular Imaging and Biology | Hwan Lee Joshua S Scheuermann Anthony J Young Robert K Doot Margaret E Daube-Witherspoon | 2022/10 |
New PSMA-Targeting Ligands: Transformation from Diagnosis (Ga-68) to Radionuclide Therapy (Lu-177) | Journal of Medicinal Chemistry | Zhihao Zha Seok Rye Choi Linlin Li Ruiyue Zhao Karl Ploessl | 2022/9/14 |
PD27-01 PREDICTING EXTRA-PROSTATIC EXTENSION (EPE) FOR SURGICAL GUIDANCE IN PROSTATE CANCER: A COMPARISON OF BIOPSY PATHOLOGY, MULTIPARAMETRIC MRI, AND PSMA-PET | The Journal of Urology | Clinton Bahler Mark Green Mark Tann Katrina Collins Jordan Swensson | 2022/5 |
Prostate-specific membrane antigen (psma) inhibitors as diagnostic and radionuclide therapeutic agents | 2022/4/28 |